| Allen, N et al., Nat Genet, 2008, Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database |
18583979 |
10.1038/ng.171 |
Cited
|
| Andersen, S et al., Pharmacogenomics, 2009, Variation in the COMT gene: implications for pain perception and pain treatment |
19374521 |
10.2217/pgs.09.13 |
Cited
|
| Aoyama, N et al., Alcohol Clin Exp Res, 2006, Genetic Factors Modulating the Response to Stimulant Drugs in Humans Association between gene polymorphisms of SLC22A3 and methamphetamine use disorder |
17010131 |
10.1111/j.1530-0277.2006.00215.x |
Cited
|
| Asherson, P et al., Am J Psychiatry, 2007, Confirmation that a specific haplotype of the dopamine transporter gene is associated with combined-type ADHD |
17403983 |
10.1176/ajp.2007.164.4.674 |
Cited
|
| Banaschewski, T et al., Eur child adolescent psychiatry, 2010, Molecular genetics of attention-deficit/hyperactivity disorder: an overview |
20145962 |
10.1007/s00787-010-0090-z |
Cited
|
| Bellgrove, MA et al., Neuropsychopharmacology, 2005, Association between dopamine transporter (DAT1) genotype, left-sided inattention, and an enhanced response to methylphenidate in attention-deficit hyperactivity disorder |
16123773 |
10.1038/sj.npp.1300839 |
Cited
|
| Bergen, A et al., Mol Psychiatry, 1997, Mu opioid receptor gene variants: lack of association with alcohol dependence |
9399694 |
10.1038/sj.mp.4000331 |
Cited
|
| Bloch, M et al., Am J Med Genet Part B Neuropsychiatr Genet, 2008, Association of the serotonin transporter polymorphism and obsessive-compulsive disorder: systematic review |
18186076 |
10.1002/ajmg.b.30699 |
Cited
|
| Bond, C et al., Proc Natl Acad Sci U S A, 1998, Single-nucleotide polymorphism in the human mu opioid receptor gene alters β-endorphin binding and activity: possible implications for opiate addiction |
9689128 |
10.1073/pnas.95.16.9608 |
Cited
|
| Brookes, K et al., Mol Psychiatry, 2006, The analysis of 51 genes in DSM-IV combined type attention deficit hyperactivity disorder: association signals in DRD4, DAT1 and 16 other genes |
16894395 |
10.1038/sj.mp.4001869 |
Cited
|
| Brown, G et al., J Affect Disord, 2008, Depression and the serotonin transporter 5-HTTLPR polymorphism: a review and a hypothesis concerning gene-environment interaction |
18534686 |
10.1016/j.jad.2008.04.009 |
Cited
|
| Brown, WA et al., Psychopharmacology (Berl), 1978, Acute psychologic and neuroendocrine effects of dextroamphetamine and methylphenidate |
98790 |
10.1007/BF00426906 |
Cited
|
| Bryant, CD et al., Psychopharmacology (Berl), 2009, A role for casein kinase 1 epsilon in the locomotor stimulant response to methamphetamine |
19050854 |
10.1007/s00213-008-1417-z |
Cited
|
| Cabeza, R et al., Curr Opin Neurol, 2000, Neural bases of learning and memory: functional neuroimaging evidence |
10970058 |
10.1097/00019052-200008000-00008 |
Cited
|
| Chen, C et al., Psychiatr Genet, Association analysis of dopamine D2-like receptor genes and methamphetamine abuse |
15564898 |
10.1097/00041444-200412000-00011 |
Cited
|
| Chen, J et al., Am J Human Genet, Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain |
15457404 |
10.1086/425589 |
Cited
|
| Cheon, K et al., Eur Neuropsychopharmacol, 2005, The homozygosity for 10-repeat allele at dopamine transporter gene and dopamine transporter density in Korean children with attention deficit hyperactivity disorder: relating to treatment response to methylphenidate |
15572278 |
10.1016/j.euroneuro.2004.06.004 |
Cited
|
| Cheon, K et al., Neuropsychopharmacology, 2006, Association of 4-repeat allele of the dopamine D4 receptor gene exon III polymorphism and response to methylphenidate treatment in Korean ADHD children |
17077808 |
10.1038/sj.npp.1301244 |
Cited
|
| Crabbe, J et al., Acta Genet Med Gemellol (Roma), 1983, Behavioral responses to amphetamines in identical twins |
6685963 |
10.1017/s0001566000006425 |
Cited
|
| Cropley, V et al., Biol Psychiatry, 2006, Molecular imaging of the dopaminergic system and its association with human cognitive function |
16682268 |
10.1016/j.biopsych.2006.03.004 |
Cited
|
| Cubells, J et al., Mol Psychiatry, 2000, A haplotype at the DBH locus, associated with low plasma dopamine β-hydroxylase activity, also associates with cocaine-induced paranoia |
10673769 |
10.1038/sj.mp.4000657 |
Cited
|
| da Silva, M et al., J Atten Disord, 2010, Lack of association between a 30UTR VNTR 776 polymorphism of dopamine transporter gene (SLC6A3) and ADHD in a Brazilian sample of 777 adult patients |
20332413 |
10.1177/1087054710365989 |
Cited
|
| Daly, J et al., Drug Alcohol Depend, 1998, Caffeine—an atypical drug of dependence |
9716941 |
10.1016/s0376-8716(98)00077-5 |
Cited
|
| David, S et al., Nicotine Tob Res, 2007, Bupropion efficacy for smoking cessation is influenced by the DRD2 Taq1A polymorphism: analysis of pooled data from two clinical trials |
18058343 |
10.1080/14622200701705027 |
Cited
|
| David, S et al., Pharmacogenomics, 2008, Genetic variation in the dopamine pathway and smoking cessation |
18781857 |
10.2217/14622416.9.9.1307 |
Cited
|
| de Wit, H et al., Behav Neurosci, 2000, Effects of d-amphetamine and ethanol on a measure of behavioral inhibition in humans |
10959541 |
10.1037//0735-7044.114.4.830 |
Cited
|
| de Wit, H et al., Drug Alcohol Depend, 1986, Individual differences in the reinforcing and subjective effects of amphetamine and diazepam |
3698813 |
10.1016/0376-8716(86)90068-2 |
Cited
|
| de Wit, H, Addict Bio, 2009, Impulsivity as a determinant and consequence of drug use: a review of underlying processes |
18855805 |
10.1111/j.1369-1600.2008.00129.x |
Cited
|
| den Hoed, M et al., Diabetes, 2010, Genetic susceptibility to obesity and related traits in childhood and adolescence; influence of loci identified by genome-wide association studies |
20724581 |
10.2337/db10-0370 |
Cited
|
| Diagnostic and statistical manual of mental disorders, 1987 |
— |
— |
—
|
| Dlugos, A et al., Biol Psychiatry, 2007, Norepinephrine transporter gene variation modulates acute response to D-amphetamine |
17239355 |
10.1016/j.biopsych.2006.09.031 |
Cited
|
| Dlugos, A et al., Genes Brain Behav, 2010, OPRM1 gene variants modulate amphetamine-induced euphoria in humans |
21029375 |
10.1111/j.1601-183X.2010.00655.x |
Cited
|
| Dlugos, AM et al., Neuropsychopharmacology, More aroused, less fatigued: fatty acid amide hydrolase gene polymorphisms influence acute response to amphetamine |
19890266 |
10.1038/npp.2009.166 |
Cited
|
| Dlugos, AM et al., Psychopharmacology (Berl), Further evidence of association between amphetamine response and SLC6A2 gene variants |
19727679 |
10.1007/s00213-009-1628-y |
Cited
|
| Drakenberg, K et al., Proc Nat Acad Sci, 2006, μ Opioid receptor A118G polymorphism in association with striatal opioid neuropeptide gene expression in heroin abusers |
16682632 |
10.1073/pnas.0600871103 |
Cited
|
| DuPaul, G et al., ADHD rating scales-IV: checklists, 1998 |
— |
— |
—
|
| Egan, MF et al., Cell, 2003, The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function |
12553913 |
10.1016/s0092-8674(03)00035-7 |
Cited
|
| Eisenberg, DTA et al., BBF, 2007, Examining impulsivity as an endophenotype using a behavioral approach: a DRD2 TaqI A and DRD4 48-bp VNTR association study |
17214892 |
10.1186/1744-9081-3-2 |
Cited
|
| Engeli, S, J Neuroendocrinol, 2008, Dysregulation of the endocannabinoid system in obesity |
18426509 |
10.1111/j.1365-2826.2008.01683.x |
Cited
|
| Ezaki, N et al., Ann N Y Acad Sci, 2008, Short allele of 5-HTTLPR as a risk factor for the development of psychosis in Japanese methamphetamine abusers |
18991848 |
10.1196/annals.1432.011 |
Cited
|
| Faraone, S et al., Am J Psychiatry, 2001, Meta-analysis of the association between the 7-repeat allele of the dopamine D4 receptor gene and attention deficit hyperactivity disorder |
11431226 |
10.1176/appi.ajp.158.7.1052 |
Cited
|
| Farrer, L et al., Arch Gen Psychiatry, 2009, Association of variants in MANEA with cocaine-related behaviors |
19255376 |
10.1001/archgenpsychiatry.2008.538 |
Cited
|
| Fergusson, D et al., Arch Gen Psychiatry, 2003, Early reactions to cannabis predict later dependence |
14557149 |
10.1001/archpsyc.60.10.1033 |
Cited
|
| Filbey, F et al., Neuropsychopharmacology, 2009, Individual and additive effects of the CNR1 and FAAH Genes on brain response to marijuana cues |
20010552 |
10.1038/npp.2009.200 |
Cited
|
| Flanagin, B et al., Am J Med Genet Part B Neuropsychiatr Genet, 2006, An association study of the brain-derived neurotrophic factor Val66Met polymorphism and amphetamine response |
16823800 |
10.1002/ajmg.b.30327 |
Cited
|
| Friedel, S et al., Mol Psychiatry, 2007, Association and linkage of allelic variants of the dopamine transporter gene in ADHD |
17579611 |
10.1038/sj.mp.4001986 |
Cited
|
| Fuke, S et al., Pharmacogenomics J, 2001, The VNTR polymorphism of the human dopamine transporter (DAT1) gene affects gene expression |
11911442 |
10.1038/sj.tpj.6500026 |
Cited
|
| Furberg, H et al., Nat Genet, 2010, Genome-wide meta-analyses identify multiple loci associated with smoking behavior |
20418890 |
10.1038/ng.571 |
Cited
|
| Fuxe, K et al., J Mol Neurosci, 2005, Adenosine A2A and dopamine D2 heteromeric receptor complexes and their function |
16012194 |
10.1385/JMN:26:2-3:209 |
Cited
|
| Gelernter, J et al., Neuropsychopharmacology, 1994, Genetic association between dopamine transporter protein alleles and cocaine-induced paranoia |
7865100 |
10.1038/sj.npp.1380106 |
Cited
|
| Greengard, P, Science, 2001, The neurobiology of slow synaptic transmission |
11691979 |
10.1126/science.294.5544.1024 |
Cited
|
| Grigorenko, E et al., Aggress Behav, 2010, Aggressive behavior, related conduct problems, and variation in genes affecting dopamine turnover |
20127808 |
10.1002/ab.20339 |
Cited
|
| Guindalini, C et al., Proc Natl Acad Sci U S A, 2006, A dopamine transporter gene functional variant associated with cocaine abuse in a Brazilian sample |
16537431 |
10.1073/pnas.0504789103 |
Cited
|
| Guy, W, ECDEU assessment manual for psychopharmacology, 1976, Clinical global impressions |
— |
— |
—
|
| Haenisch, B et al., Am J Med Genet Part B Neuropsychiatr Genet, 2009, Association of major depression with rare functional variants in norepinephrine transporter and serotonin1A receptor genes |
19105200 |
10.1002/ajmg.b.30912 |
Cited
|
| Haertzen, C et al., Drug Alcohol Depend, 1983, Reinforcements from the first drug experience can predict later drug habits and/or addiction: results with coffee, cigarettes, alcohol, barbiturates, minor and major tranquilizers, stimulants, marijuana, hallucinogens, heroin, opiates and cocaine |
6134605 |
10.1016/0376-8716(83)90076-5 |
Cited
|
| Hamarman, S et al., J Child Adolescent Psychopharmacology, 2004, Dopamine receptor 4 (DRD4) 7-repeat allele predicts methylphenidate dose response in children with attention deficit hyperactivity disorder: a pharmacogenetic study |
15662148 |
10.1089/cap.2004.14.564 |
Cited
|
| Hamidovic, A et al., Behav Genet, Polymorphisms in dopamine transporter (SLC6A3) are associated with stimulant effects of d-amphetamine: an exploratory pharmacogenetic study using healthy volunteers |
20091113 |
10.1007/s10519-009-9331-7 |
Cited
|
| Hamidovic, A et al., Exp Clin Psychopharmacol, 2009, Evaluation of genetic variability in the dopamine receptor D2 in relation to behavioral inhibition and impulsivity/sensation seeking: an exploratory study with d-amphetamine in healthy participants |
19968402 |
10.1037/a0017840 |
Cited
|
| Hamidovic, A et al., Psychiatr Genet, Catechol-O-methyltransferase val158met genotype modulates sustained attention in both the drug-free state and in response to amphetamine |
20414144 |
10.1097/YPG.0b013e32833a1f3c |
Cited
|
| Hashimoto, K et al., Brain Res Rev, 2004, Critical role of brain-derived neurotrophic factor in mood disorders |
15145621 |
10.1016/j.brainresrev.2004.02.003 |
Cited
|
| Heaton, RK et al., Wisconsin card sorting test manual, 1993 |
— |
— |
—
|
| Hohoff, C et al., Am J Med Genet Part B Neuropsychiatr Genet, 2005, Interindividual variation in anxiety response to amphetamine: possible role for adenosine A2A receptor gene variants |
16118787 |
10.1002/ajmg.b.30228 |
Cited
|
| Holdstock, L et al., Alcohol Clin Exp Res, 2001, Individual differences in responses to ethanol and d-amphetamine: a within-subject study |
11329494 |
— |
Cited
|
| Hranilovic, D et al., Biol Psychiatry, 2004, Serotonin transporter promoter and intron 2 polymorphisms: relationship between allelic variants and gene expression |
15158428 |
10.1016/j.biopsych.2004.01.029 |
Cited
|
| Hu, X et al., Am J Human Genet, 2006, Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder |
16642437 |
10.1086/503850 |
Cited
|
| Huang, C et al., Am J Med Genet Part B: Neuropsychiatr Genet, 2008, Autism and serotonin transporter gene polymorphisms: a systematic review and meta-analysis |
18286633 |
10.1002/ajmg.b.30720 |
Cited
|
| Hyman, C et al., Nature, 1991, BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra |
2005978 |
10.1038/350230a0 |
Cited
|
| Ide, S et al., Ann N Y Acad Sci, 2004, Gene polymorphisms of the mu opioid receptor in methamphetamine abusers |
15542732 |
10.1196/annals.1316.039 |
Cited
|
| Ide, S et al., Pharmacogenomics J, 2006, Linkage disequilibrium and association with methamphetamine dependence/psychosis of mu-opioid receptor gene polymorphisms |
16402083 |
10.1038/sj.tpj.6500355 |
Cited
|
| Johanson, C et al., Psychopharmacology (Berl), 1980, Drug preference and mood in humans: diazepam |
6779334 |
10.1007/BF00433061 |
Cited
|
| Johansson, I et al., Cytogenet Genome Res, 2008, CNVs of human genes and their implication in pharmacogenetics |
19287156 |
10.1159/000184709 |
Cited
|
| Johansson, S et al., Am J Med Genet Part B Neuropsychiatr Genet, 2008, Genetic analyses of dopamine related genes in adult ADHD patients suggest an association with the DRD5-microsatellite repeat, but not with DRD4 or SLC6A3 VNTRs |
18081165 |
10.1002/ajmg.b.30662 |
Cited
|
| Joober, R et al., Neuropsychopharmacology, 2007, Dopamine transporter 3′-UTR VNTR genotype and ADHD: a pharmaco-behavioural genetic study with methylphenidate |
17063150 |
10.1038/sj.npp.1301240 |
Cited
|
| Kalayasiri, R et al., Biol Psychiatry, 2007, Dopamine beta-hydroxylase gene (DbetaH) -1021C–>T influences self-reported paranoia during cocaine self-administration |
17157269 |
10.1016/j.biopsych.2006.08.012 |
Cited
|
| Kato, M et al., Mol Psychiatry, 2008, Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder |
18982004 |
10.1038/mp.2008.116 |
Cited
|
| Kaufman, J et al., J Am Acad Child Adolesc Psychiatry, 1997, Schedule for affective disorders and schizophrenia for school-age children-present and lifetime version (K-SADS-PL): initial reliability and validity data |
9204677 |
10.1097/00004583-199707000-00021 |
Cited
|
| Kaufman, S et al., Pharmacol Rev, 1965, Dopamine-β-hydroxylase |
14294032 |
— |
Cited
|
| Kendler, K et al., Acta Psychiatr Scand, 1999, Hallucinogen, opiate, sedative and stimulant use and abuse in a population-based sample of female twins |
10353453 |
10.1111/j.1600-0447.1999.tb07243.x |
Cited
|
| Kendler, K et al., Psychol Med, 2005, Genetic and environmental influences on illicit drug use and tobacco use across birth cohorts |
16168157 |
10.1017/S0033291705004964 |
Cited
|
| Kendler, KS et al., Am J Psychiatry, 2003, Specificity of genetic and environmental risk factors for use and abuse/dependence of cannabis, cocaine, hallucinogens, sedatives, stimulants, and opiates in male twins |
12668357 |
10.1176/appi.ajp.160.4.687 |
Cited
|
| Kendler, KS et al., Arch Gen Psychiatry, 2000, Illicit psychoactive substance use, heavy use, abuse, and dependence in a US population-based sample of male twins |
10711912 |
10.1001/archpsyc.57.3.261 |
Cited
|
| Kirchner, WK, J Exp Psychology, 1958, Age differences in short-term retention of rapidly changing information |
13539317 |
10.1037/h0043688 |
Cited
|
| Kishi, T et al., Prog Neuropsychopharmacol Biol Psychiatry, 2010, PROKR2 is associated with methamphetamine dependence in the Japanese population |
20576534 |
10.1016/j.pnpbp.2010.05.018 |
Cited
|
| Kishimoto, M et al., Behav Brain Funct, The frizzled 3 gene is associated with methamphetamine psychosis in the Japanese population |
18702828 |
10.1186/1744-9081-4-37 |
Cited
|
| Kishimoto, M et al., Biol Psychiatry, The dysbindin gene (DTNBP1) is associated with methamphetamine psychosis |
17555717 |
10.1016/j.biopsych.2007.03.019 |
Cited
|
| Kobayashi, H et al., Ann N Y Acad Sci, 2004, Study of association between alpha-synuclein gene polymorphism and methamphetamine psychosis/dependence |
15542733 |
10.1196/annals.1316.040 |
Cited
|
| Kooij, J et al., Am J Med Genet Part B: Neuropsychiatr Genet, 2008, Response to methylphenidate in adults with ADHD is associated with a polymorphism in SLC6A3 (DAT1) |
17955457 |
10.1002/ajmg.b.30586 |
Cited
|
| Kotaka, T et al., Prog Neuropsychopharmacol Biol Psychiatry, 2009, G72 gene is associated with susceptibility to methamphetamine psychosis |
19482054 |
10.1016/j.pnpbp.2009.05.017 |
Cited
|
| Kreek, M et al., Nat Neurosci, 2005, Genetic influences on impulsivity, risk taking, stress responsivity and vulnerability to drug abuse and addiction |
16251987 |
10.1038/nn1583 |
Cited
|
| Lachman, H et al., Pharmacogenet Genomics, 1996, Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders |
8807664 |
10.1097/00008571-199606000-00007 |
Cited
|
| Lamb, RJ et al., J Exp Anal Behav, 1994, Human d-amphetamine drug discrimination: methamphetamine and hydromorphone |
7513346 |
10.1901/jeab.1994.61-169 |
Cited
|
| Laucht, M et al., J Am Acad Child Adolesc Psychiatry, 2008, Genetic variation in dopamine pathways differentially associated with smoking progression in adolescence |
18434921 |
10.1097/CHI.0b013e31816bff77 |
Cited
|
| Lee, A et al., 2006, DRD4-7R mediated response to amphetamine in normal subjects |
— |
— |
—
|
| Lee, Y et al., Neurosci Lett, 2005, Norepinephrine transporter (NET) promoter and 5′-UTR polymorphisms: association analysis in panic disorder |
15722184 |
10.1016/j.neulet.2004.11.063 |
Cited
|
| Levran, O et al., Genes Brain Behav, 2008, Genetic susceptibility to heroin addiction: a candidate gene association study |
18518925 |
10.1111/j.1601-183X.2008.00410.x |
Cited
|
| Li, D et al., Hum Mol Genet, 2006, Meta-analysis shows significant association between dopamine system genes and attention deficit hyperactivity disorder (ADHD) |
16774975 |
10.1093/hmg/ddl152 |
Cited
|
| Li, T et al., Am J Med Genet Part B Neuropsychiatr Genet, 2004, Association analysis of the DRD4 and COMT genes in methamphetamine abuse |
15274053 |
10.1002/ajmg.b.30024 |
Cited
|
| Lichter, J et al., Hum Mol Genet, 1993, A hypervariable segment in the human dopamine receptor D4 (DRD4) gene |
8353495 |
10.1093/hmg/2.6.767 |
Cited
|
| Lin, L et al., Drug Metab Dispos, 1997, Oxidation of methamphetamine and methylenedioxymethamphetamine by CYP2D6 |
9311621 |
— |
Cited
|
| Logan, G et al., J Exp Psychology, 1984, On the ability to inhibit simple and choice reaction time responses: a model and a method |
6232345 |
10.1037//0096-1523.10.2.276 |
Cited
|
| Lohoff, F et al., Neuropsychopharmacology, 2008, Association between the catechol-O-methyltransferase Val158Met polymorphism and cocaine dependence |
18704099 |
10.1038/npp.2008.126 |
Cited
|
| Lott, D et al., Am J Addict, 2006, Serotonin transporter genotype and acute subjective response to amphetamine |
16966188 |
10.1080/10550490600859868 |
Cited
|
| Lott, D et al., Neuropsychopharmacology, 2005, Dopamine transporter gene associated with diminished subjective response to amphetamine |
15602501 |
10.1038/sj.npp.1300637 |
Cited
|
| Madsen, MV et al., J Psychopharmacol (Oxford), 2006, Effects of the cannabinoid CB1 receptor agonist CP55, 940 and antagonist SR141716A on d-amphetamine-induced behaviours in Cebus monkeys |
16533866 |
10.1177/0269881106063816 |
Cited
|
| Manor, I et al., Am J Med Genet Part B Neuropsychiatr Genet, 2008, Association between trypotphan hydroxylase 2, performance on a continuance performance test and response to methylphenidate in ADHD participants |
18213624 |
10.1002/ajmg.b.30702 |
Cited
|
| Martin, WRSJW et al., Clin Pharmacol Therap, 1971, Physiologic, subjective and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine and methylphenidate in man |
5554941 |
10.1002/cpt1971122part1245 |
Cited
|
| Matsuzawa, D et al., Am J Psychiatry, 2007, Identification of functional polymorphisms in the promoter region of the human PICK1 gene and their association with methamphetamine psychosis |
17606663 |
10.1176/ajp.2007.164.7.1105 |
Cited
|
| Mattay, V et al., Proc Natl Acad Sci U S A, 2003, Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine |
12716966 |
10.1073/pnas.0931309100 |
Cited
|
| McGough, J et al., J Am Acad Child Adolesc Psychiatry, 2006, Pharmacogenetics of methylphenidate response in preschoolers with ADHD |
17023870 |
10.1097/01.chi.0000235083.40285.08 |
Cited
|
| McKinney, MK et al., Annu Rev Biochem, 2005, Structure and function of fatty acid amide hydrolase |
15952893 |
10.1146/annurev.biochem.74.082803.133450 |
Cited
|
| McNair, D et al., POMS manual for profile of mood states, 1971 |
— |
— |
—
|
| Mick, E et al., Am J Med Genet Part B Neuropsychiatr Genet, 2008, Genome-wide association study of response to methylphenidate in 187 children with attention-deficit/hyperactivity disorder |
18821564 |
10.1002/ajmg.b.30865 |
Cited
|
| Mick, E et al., J Am Acad Child Adolesc Psychiatry, 2010, Family-based genome-wide association scan of attention-deficit/hyperactivity disorder |
20732626 |
10.1016/j.jaac.2010.02.014 |
Cited
|
| Min, W et al., Psychopharmacology (Berl), 2009, Monoamine transporter gene polymorphisms affect susceptibility to depression and predict antidepressant response |
19468717 |
10.1007/s00213-009-1550-3 |
Cited
|
| Morita, Y et al., Am J Med Genet B Neuropsychiatr Genet, 2008, The glycine transporter 1 gene (GLYT1) is associated with methamphetamine-use disorder |
17582620 |
10.1002/ajmg.b.30565 |
Cited
|
| Munafò, M et al., Biol Psychiatry, 2008, Association of the dopamine D4 receptor (DRD4) gene and approach-related personality traits: meta-analysis and new data |
17574217 |
10.1016/j.biopsych.2007.04.006 |
Cited
|
| Nakamura, K et al., Hum Genet, 2006, Association analysis of SOD2 variants with methamphetamine psychosis in Japanese and Taiwanese populations |
16807759 |
10.1007/s00439-006-0189-y |
Cited
|
| Nakamura, K et al., Neurosci Lett, 2009, An association study of monoamine oxidase A (MAOA) gene polymorphism in methamphetamine psychosis |
19368859 |
10.1016/j.neulet.2009.02.048 |
Cited
|
| Nakamura, M et al., Mol Psychiatry, 2000, The human serotonin transporter gene linked polymorphism (5-HTTLPR) shows ten novel allelic variants |
10673766 |
10.1038/sj.mp.4000698 |
Cited
|
| Nakatome, M et al., Leg Med (Tokyo), 2009, Association between the GST genetic polymorphisms and methamphetamine abusers in the Japanese population |
19254865 |
10.1016/j.legalmed.2009.01.095 |
Cited
|
| Nemoda, Z et al., Neuropharmacology, 2009, Carboxylesterase 1 gene polymorphism and methylphenidate response in ADHD |
19733552 |
10.1016/j.neuropharm.2009.08.014 |
Cited
|
| Neville, M et al., Hum Mutat, 2004, Identification and characterization of ANKK1: a novel kinase gene closely linked to DRD2 on chromosome band 11q23. 1 |
15146457 |
10.1002/humu.20039 |
Cited
|
| Nishiyama, T et al., Pharmacogenomics J, 2005, Haplotype association between GABAA receptor gamma2 subunit gene (GABRG2) and methamphetamine use disorder |
15772696 |
10.1038/sj.tpj.6500292 |
Cited
|
| Nomura, A et al., Neurosci Lett, 2006, Genetic variant of prodynorphin gene is risk factor for methamphetamine dependence |
16529859 |
10.1016/j.neulet.2006.02.038 |
Cited
|
| Nurnberger, J et al., Psychoneuroendocrinology, 1982, Behavioral, biochemical and neuroendocrine responses to amphetamine in normal twins and ‘well-state’ bipolar patients |
6891082 |
10.1016/0306-4530(82)90009-9 |
Cited
|
| Ohgake, S et al., Addict Bio, 2005, Functional polymorphism of the NQO2 gene is associated with methamphetamine psychosis |
16191666 |
10.1080/13556210500123423 |
Cited
|
| Oroszi, G et al., Alcohol Clin Exp Res, 2009, OPRM1 Asn40Asp predicts response to naltrexone treatment: a haplotype-based approach |
19053977 |
10.1111/j.1530-0277.2008.00846.x |
Cited
|
| Otani, K et al., Neurosci Lett, 2008, Reduced CYP2D6 activity is a negative risk factor for methamphetamine dependence |
18280655 |
10.1016/j.neulet.2008.01.033 |
Cited
|
| Palmer, AA et al., Mamm Genome, 2005, Gene expression differences in mice divergently selected for methamphetamine sensitivity |
16104378 |
10.1007/s00335-004-2451-8 |
Cited
|
| Phillips, T et al., Neurosci Biobehav Rev, 2008, Behavioral genetic contributions to the study of addiction-related amphetamine effects |
18207241 |
10.1016/j.neubiorev.2007.10.008 |
Cited
|
| Purper-Ouakil, D et al., Am J Med Genet Part B Neuropsychiatr Genet, 2008, Pharmacogenetics of methylphenidate response in attention deficit/hyperactivity disorder: association with the dopamine transporter gene (SLC6A3) |
18563707 |
10.1002/ajmg.b.30809 |
Cited
|
| Rausch, J, Prog Neuropsychopharmacol Biol Psychiatry, 2005, Initial conditions of psychotropic drug response: studies of serotonin transporter long promoter region (5-HTTLPR), serotonin transporter efficiency, cytokine and kinase gene expression relevant to depression and antidepressant outcome |
16005136 |
10.1016/j.pnpbp.2005.03.011 |
Cited
|
| Reitan, R, Percept Mot Skills, 1958, Validity of the trail making test as an indicator of organic brain damage |
— |
— |
—
|
| Risch, N et al., JAMA, 2009, Interaction between the serotonin transporter gene (5-HTTLPR), stressful life events, and risk of depression: a meta-analysis |
19531786 |
10.1001/jama.2009.878 |
Cited
|
| Rodriguez-Jimenez, R et al., Eur Psychiatry, 2006, The TaqIA polymorphism linked to the DRD2 gene is related to lower attention and less inhibitory control in alcoholic patients |
16139486 |
10.1016/j.eurpsy.2005.05.010 |
Cited
|
| Rohde, L et al., Synapse, 2003, Dopamine transporter gene, response to methylphenidate and cerebral blood flow in attention-deficit/hyperactivity disorder: a pilot study |
12619042 |
10.1002/syn.10186 |
Cited
|
| Roman, T et al., Am J Med Genet Part B: Neuropsychiatr Genet, 2001, Attention-deficit hyperactivity disorder: a study of association with both the dopamine transporter gene and the dopamine D4 receptor gene |
11449401 |
10.1002/ajmg.1408 |
Cited
|
| Rosvold, HE et al., J Consult Psychology, 1956, A continuous performance test of brain damage |
13367264 |
10.1037/h0043220 |
Cited
|
| Sabol, SZ et al., Hum Genet, 1998, A functional polymorphism in the monoamine oxidase A gene promoter |
9799080 |
10.1007/s004390050816 |
Cited
|
| Seiden, L et al., Annu Rev Pharmacol Toxicol, 1993, Amphetamine: effects on catecholamine systems and behavior |
8494354 |
10.1146/annurev.pa.33.040193.003231 |
Cited
|
| Sekine, Y et al., Arch Gen Psychiatry, 2006, Brain serotonin transporter density and aggression in abstinent methamphetamine abusers |
16389202 |
10.1001/archpsyc.63.1.90 |
Cited
|
| Sevak, RJ et al., J Pharmacol Exp Ther, 2009, Discriminative stimulus and subject-rated effects of methamphetamine, d-amphetamine, methylphenidate, and triazolam in methamphetamine-trained humans |
19104030 |
10.1124/jpet.108.147124 |
Cited
|
| Shi, J et al., Schizophr Res, 2008, Genetic associations with schizophrenia: meta-analyses of 12 candidate genes |
18715757 |
10.1016/j.schres.2008.06.016 |
Cited
|
| Shugart, Y et al., Eur J Hum Genet, 2009, Two British women studies replicated the association between the Val66Met polymorphism in the brain-derived neurotrophic factor (BDNF) and BMI |
19209189 |
10.1038/ejhg.2008.272 |
Cited
|
| Spanagel, R et al., Proc Natl Acad Sci, 1992, Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway |
1347943 |
10.1073/pnas.89.6.2046 |
Cited
|
| Stein, M et al., Neuropsychopharmacology, 2005, Dopamine transporter genotype and methylphenidate dose response in children with ADHD |
15827573 |
10.1038/sj.npp.1300718 |
Cited
|
| Stroop, J, J Exp Psychology, 1935, Studies of interference in serial verbal reactions |
— |
— |
—
|
| Sulzer, D et al., Prog Neurobiol, 2005, Mechanisms of neurotransmitter release by amphetamines: a review |
15955613 |
10.1016/j.pneurobio.2005.04.003 |
Cited
|
| Suzuki, A et al., Psychiatr Genet, 2006, An association study between catechol-O-methyl transferase gene polymorphism and methamphetamine psychotic disorder |
16829779 |
10.1097/01.ypg.0000218613.35139.cd |
Cited
|
| Thakur, G et al., BMC Psychiatry, 2010, The 5-HTTLPR polymorphism of the serotonin transporter gene and short term behavioral response to methylphenidate in children with ADHD |
20569447 |
10.1186/1471-244X-10-50 |
Cited
|
| Tsuang, MT et al., Am J Med Genet, 1996, Genetic influences on DSM-III-R drug abuse and dependence: a study of 3,372 twin pairs |
8886164 |
10.1002/(SICI)1096-8628(19960920)67:5<473::AID-AJMG6>3.0.CO;2-L |
Cited
|
| Tsunoka, T et al., Prog Neuropsychopharmacol Biol Psychiatry, 2010, Association analysis of GRM2 and HTR2A with methamphetamine-induced psychosis and schizophrenia in the Japanese population |
20211215 |
10.1016/j.pnpbp.2010.03.002 |
Cited
|
| Tunbridge, E et al., Biol Psychiatry, 2006, Catechol-o-methyltransferase, cognition, and psychosis: Val158Met and beyond |
16476412 |
10.1016/j.biopsych.2005.10.024 |
Cited
|
| Uhl, G et al., FASEB J, 2000, The VMAT2 gene in mice and humans: amphetamine responses, locomotion, cardiac arrhythmias, aging, and vulner-ability to dopaminergic toxins |
11099463 |
10.1096/fj.00-0205rev |
Cited
|
| Uhl, G, NeuroRx, 2006, Molecular genetics of addiction vulnerability |
16815213 |
10.1016/j.nurx.2006.05.006 |
Cited
|
| Uhl, GR et al., Arch Gen Psychiatry, 2008, Genome-wide association for methamphetamine dependence: convergent results from 2 samples |
18316681 |
10.1001/archpsyc.65.3.345 |
Cited
|
| Ujike, H et al., Pharmacogenomics J, 2003, Nine- or fewer repeat alleles in VNTR polymorphism of the dopamine transporter gene is a strong risk factor for prolonged methamphetamine psychosis |
12931138 |
10.1038/sj.tpj.6500189 |
Cited
|
| Ujike, H et al., Prog Neuropsychopharmacol Biol Psychiatry, 2009, Genetic variants of D2 but not D3 or D4 dopamine receptor gene are associated with rapid onset and poor prognosis of methamphetamine psychosis |
19275926 |
10.1016/j.pnpbp.2009.02.019 |
Cited
|
| van de Giessen, E et al., J Nucl Med, 2009, Striatal dopamine transporter availability associated with polymorphisms in the dopamine transporter gene SLC6A3 |
19091889 |
10.2967/jnumed.108.053652 |
Cited
|
| Van Dyck, C et al., J Nucl Med, 2005, Increased dopamine transporter availability associated with the 9-repeat allele of the SLC6A3 gene |
15872345 |
— |
Cited
|
| Vandenbergh, D et al., Genomics, 1992, Human dopamine transporter gene (DAT1) maps to chromosome 5p15. 3 and displays a VNTR |
1478653 |
10.1016/s0888-7543(05)80138-7 |
Cited
|
| Vandenbergh, DJ et al., Am J Med Genet, 1997, High-activity catechol-O-methyltransferase allele is more prevalent in polysubstance abusers |
9259381 |
— |
Cited
|
| Veenstra-VanderWeele, J et al., Neuropsychopharmacology, 2006, Association between the casein kinase 1 epsilon gene region and subjective response to D-amphetamine |
16237383 |
10.1038/sj.npp.1300936 |
Cited
|
| Warwick, JM, Metab Brain Dis, 2004, Imaging of brain function using SPECT |
15214511 |
10.1023/b:mebr.0000027422.48744.a3 |
Cited
|
| Wechsler, D, Acad Med, 1958, The measurement and appraisal of adult intelligence |
— |
— |
—
|
| Yang, A et al., Psychopharmacology (Berl), 2010, Genetics of caffeine consumption and responses to caffeine |
20532872 |
10.1007/s00213-010-1900-1 |
Cited
|
| Yu, Y et al., Hum Genet, 2008, Substance dependence low-density whole genome association study in two distinct American populations |
18438686 |
10.1007/s00439-008-0501-0 |
Cited
|
| Zabetian, C et al., Am J Human Genet, 2001, A quantitative-trait analysis of human plasma-dopamine [beta]-hydroxylase activity: evidence for a major functional polymorphism at the DBH locus |
11170900 |
10.1086/318198 |
Cited
|
| Zabetian, C et al., Am J Human Genet, 2003, The structure of linkage disequilibrium at the DBH locus strongly influences the magnitude of association between diallelic markers and plasma dopamine [beta]-hydroxylase activity |
12730829 |
10.1086/375499 |
Cited
|
| Zhang, X et al., Cell Mol Life Sci, 2006, Functional polymorphisms of the brain serotonin synthesizing enzyme tryptophan hydroxylase-2 |
16378243 |
10.1007/s00018-005-5417-4 |
Cited
|
| Zhang, Y et al., Proc Nat Acad Sci, 2007, Polymorphisms in human dopamine D2 receptor gene affect gene expression, splicing, and neuronal activity during working memory |
18077373 |
10.1073/pnas.0707106104 |
Cited
|
| Šerý, O et al., J Mol Neurosci, 2010, A118G polymorphism of OPRM1 gene is associated with schizophrenia |
20112002 |
10.1007/s12031-010-9327-z |
Cited
|
| Šerý, O et al., Physiol Res, 2001, The association study of DRD2, ACE and AGT gene polymorphisms and metamphetamine dependence |
11300226 |
— |
Cited
|
